JPS63291594A - Determination of hydrogen peroxide - Google Patents
Determination of hydrogen peroxideInfo
- Publication number
- JPS63291594A JPS63291594A JP12786087A JP12786087A JPS63291594A JP S63291594 A JPS63291594 A JP S63291594A JP 12786087 A JP12786087 A JP 12786087A JP 12786087 A JP12786087 A JP 12786087A JP S63291594 A JPS63291594 A JP S63291594A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen peroxide
- manganese
- xod
- measurement
- cobalt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 64
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052748 manganese Inorganic materials 0.000 claims abstract description 13
- 239000011572 manganese Substances 0.000 claims abstract description 13
- 229910017052 cobalt Inorganic materials 0.000 claims abstract description 10
- 239000010941 cobalt Substances 0.000 claims abstract description 10
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 239000002738 chelating agent Substances 0.000 claims abstract description 9
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 9
- 108010093894 Xanthine oxidase Proteins 0.000 claims abstract description 6
- 102100033220 Xanthine oxidase Human genes 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 42
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000004445 quantitative analysis Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 34
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 abstract description 2
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 abstract description 2
- 150000002736 metal compounds Chemical class 0.000 abstract description 2
- 238000004737 colorimetric analysis Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 36
- 239000000126 substance Substances 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 14
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 13
- 229910052698 phosphorus Inorganic materials 0.000 description 13
- 239000011574 phosphorus Substances 0.000 description 13
- 238000011088 calibration curve Methods 0.000 description 11
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 10
- -1 superoxide anions Chemical class 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 7
- 229940075420 xanthine Drugs 0.000 description 5
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 4
- 229930010555 Inosine Natural products 0.000 description 4
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 description 4
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960003786 inosine Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 3
- 102000055025 Adenosine deaminases Human genes 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 108010012029 Guanine Deaminase Proteins 0.000 description 3
- 102000013587 Guanine deaminase Human genes 0.000 description 3
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RNMCCPMYXUKHAZ-UHFFFAOYSA-N 2-[3,3-diamino-1,2,2-tris(carboxymethyl)cyclohexyl]acetic acid Chemical compound NC1(N)CCCC(CC(O)=O)(CC(O)=O)C1(CC(O)=O)CC(O)=O RNMCCPMYXUKHAZ-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 239000007991 ACES buffer Substances 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 150000001869 cobalt compounds Chemical class 0.000 description 2
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- QGBLCIBATKETJC-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;manganese(2+) Chemical compound [Mn+2].O1B([O-])OB2OB([O-])OB1O2 QGBLCIBATKETJC-UHFFFAOYSA-N 0.000 description 1
- KZCZKGOYMZDJKY-UHFFFAOYSA-L 4-aminobenzoate manganese(2+) Chemical compound [Mn++].Nc1ccc(cc1)C([O-])=O.Nc1ccc(cc1)C([O-])=O KZCZKGOYMZDJKY-UHFFFAOYSA-L 0.000 description 1
- QZKJUBKNJKLMIB-UHFFFAOYSA-L 4-cyclohexylbutanoate;manganese(2+) Chemical compound [Mn+2].[O-]C(=O)CCCC1CCCCC1.[O-]C(=O)CCCC1CCCCC1 QZKJUBKNJKLMIB-UHFFFAOYSA-L 0.000 description 1
- GGZZISOUXJHYOY-UHFFFAOYSA-N 8-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(N)=CC=CC2=C1O GGZZISOUXJHYOY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 108010015428 Bilirubin oxidase Proteins 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- SXFQDYORBVIULR-UHFFFAOYSA-N azane;cobalt(2+) Chemical compound N.[Co+2] SXFQDYORBVIULR-UHFFFAOYSA-N 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical class C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- BLMXJJXSWRYMCS-UHFFFAOYSA-L butanoate;manganese(2+) Chemical compound [Mn+2].CCCC([O-])=O.CCCC([O-])=O BLMXJJXSWRYMCS-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 229940011182 cobalt acetate Drugs 0.000 description 1
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 description 1
- 229910001429 cobalt ion Inorganic materials 0.000 description 1
- 229910001981 cobalt nitrate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- QAHREYKOYSIQPH-UHFFFAOYSA-L cobalt(II) acetate Chemical compound [Co+2].CC([O-])=O.CC([O-])=O QAHREYKOYSIQPH-UHFFFAOYSA-L 0.000 description 1
- BZRRQSJJPUGBAA-UHFFFAOYSA-L cobalt(ii) bromide Chemical compound Br[Co]Br BZRRQSJJPUGBAA-UHFFFAOYSA-L 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- RJYMRRJVDRJMJW-UHFFFAOYSA-L dibromomanganese Chemical compound Br[Mn]Br RJYMRRJVDRJMJW-UHFFFAOYSA-L 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical class C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- QAMFBRUWYYMMGJ-UHFFFAOYSA-N hexafluoroacetylacetone Chemical compound FC(F)(F)C(=O)CC(=O)C(F)(F)F QAMFBRUWYYMMGJ-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- QTWZICCBKBYHDM-UHFFFAOYSA-N leucomethylene blue Chemical class C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 1
- 229940071125 manganese acetate Drugs 0.000 description 1
- 239000011656 manganese carbonate Substances 0.000 description 1
- 235000006748 manganese carbonate Nutrition 0.000 description 1
- 229940093474 manganese carbonate Drugs 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 1
- QMZIDZZDMPWRHM-UHFFFAOYSA-L manganese(2+);dibenzoate Chemical compound [Mn+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 QMZIDZZDMPWRHM-UHFFFAOYSA-L 0.000 description 1
- BHVPEUGTPDJECS-UHFFFAOYSA-L manganese(2+);diformate Chemical compound [Mn+2].[O-]C=O.[O-]C=O BHVPEUGTPDJECS-UHFFFAOYSA-L 0.000 description 1
- MIVBAHRSNUNMPP-UHFFFAOYSA-N manganese(2+);dinitrate Chemical compound [Mn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MIVBAHRSNUNMPP-UHFFFAOYSA-N 0.000 description 1
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 description 1
- SQZZGEUJERGRIN-UHFFFAOYSA-N manganese;pentane-2,4-dione Chemical compound [Mn].CC(=O)CC(C)=O SQZZGEUJERGRIN-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002212 purine nucleoside Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、キサンチンオキシダーゼ(以下、XODと略
称する。)の作用を介して生成する過酸[発明の背景]
核酸代謝にl4する酵素であるグアナーゼ、アデノシン
デアミナーゼ、プリンヌクレオシドホスホリラーゼ等、
或はそれらの酵素による代謝産物であるイノシン、ヒボ
キサンチン、キサンチン等、又はプリンヌクレオシドボ
スホリラーゼの基質となる電機リン等は、臨床検査の分
野に於いては、重要な測定項目の−ってあり、これらの
正確で簡便な測定法の確立は近時重要な課題となってき
ている。Detailed Description of the Invention [Industrial Application Field] The present invention relates to peracid produced through the action of xanthine oxidase (hereinafter abbreviated as XOD) [Background of the Invention] An enzyme involved in nucleic acid metabolism. Certain guanase, adenosine deaminase, purine nucleoside phosphorylase, etc.
In the field of clinical testing, inosine, hypoxanthine, xanthine, etc., which are metabolites of these enzymes, and electrophosphorus, which is the substrate of purine nucleoside bosphorylase, are important measurement items in the field of clinical testing. , the establishment of accurate and simple measurement methods has recently become an important issue.
これら核酸代謝に藺与する物質の測定法としては、例え
ばグアナーゼの場合には基質プリンの減少を紫外部吸光
度変化で測定する方法(Arch、Biochem、、
2Q、124頁、 1950)、生成物であるアンモニ
アを測定する方法(Cancer Res、、12,5
24頁、+952)、生成物であるキサンチンにXOD
を作用させて生じる尿酸を測定するか(J、Biol、
Chelg、、167.461頁。As a method for measuring these substances that contribute to nucleic acid metabolism, for example, in the case of guanase, the decrease in the substrate purine is measured by changes in ultraviolet absorbance (Arch, Biochem,
2Q, p. 124, 1950), a method for measuring the product ammonia (Cancer Res, 12, 5
p. 24, +952), XOD to the product xanthine
(J, Biol,
Chelg,, 167.461 pages.
アデノシンデアミナーゼの測定については、生成物であ
るアンモニアを測定する方法(J、Biol 、che
■、、+67.445頁、+947)、プリンヌクレオ
シドホスホリラーセ及びXODを介在させることにより
生成物のイノシンを尿酸と過酸化水素に変換させ、生し
た過酸化水素を測定する方法(Che+g、Pharn
+、Bul 1、.29,426頁、+981)等が知
られている。For the measurement of adenosine deaminase, a method for measuring the product ammonia (J, Biol, Che.
■,, +67.445 pages, +947), a method of converting the product inosine into uric acid and hydrogen peroxide through purine nucleoside phosphorylase and XOD, and measuring the hydrogen peroxide produced (Che+g, Pharn
+, Bul 1, . 29,426 pages, +981), etc. are known.
しかし、アンモニアを測定する方法、基質プリンの減少
を紫外部吸光度変化で測定する方法或は生成物である尿
酸を測定する方法では試料中の内因性アンモニア、紫外
吸光物質或は尿酸の影響を受けるため試料ブランク値の
測定を実施しても、測定結果が不正確となる場合がある
。However, methods that measure ammonia, methods that measure the decrease in substrate purines by changes in ultraviolet absorbance, or methods that measure the product uric acid are affected by endogenous ammonia, ultraviolet absorbing substances, or uric acid in the sample. Therefore, even if a sample blank value is measured, the measurement result may be inaccurate.
一方、ヒボキサンチン(或はキサンチン)を基質として
、XODの作用により生成する過酸化水素を測定する方
法に於いては、過酸化水素のほかにもスーパーオキサイ
ドアニオン(0=2)が同時に生成し、しかも過酸化水
素とスーパーオキサイドアニオンの生成比はpH或は基
質濃度によって変化しくJ、Biol、Chem、、υ
15,4053頁、 +970)、過酸化水素とスーパ
ーオキサイドアニオンが直接反応して過酸化水素が分解
されたり、或は過酸化水素とパーオキシダーゼ(以下、
PODと略称する。)の反応を介して生成する色素をス
ーパーオキサイドアニオンが還元したりするために、実
測された過酸化水素生成量は紫外部吸光度測定により求
めたノ、%質減少量から算出した過酸化水素の理論的生
成績よりも低かったり、生成する色素量が過酸化水素の
理論的生成績に比例しないと言う現象が生し、しかもこ
のような現象は測定条件により変化するため、この反応
を利用して物質の定量を行った場合には低濃度域での測
定しか信頼性がない等の問題があった。On the other hand, in the method of measuring hydrogen peroxide produced by the action of XOD using hyboxanthin (or xanthine) as a substrate, superoxide anion (0 = 2) is simultaneously produced in addition to hydrogen peroxide, Moreover, the production ratio of hydrogen peroxide and superoxide anion varies depending on the pH or substrate concentration, J, Biol, Chem, υ
15, p. 4053, +970), hydrogen peroxide and superoxide anion react directly to decompose hydrogen peroxide, or hydrogen peroxide and peroxidase (hereinafter referred to as
It is abbreviated as POD. ) Since the superoxide anion reduces the dye produced through the reaction of This reaction may be lower than the theoretical yield or the amount of dye produced may not be proportional to the theoretical yield of hydrogen peroxide, and these phenomena vary depending on the measurement conditions. When quantifying substances, there were problems such as the reliability of measurements only in low concentration ranges.
その為、XODの作用により生成する過酸化水素を測定
する方法に於いてはこれらの問題点を解決すべく種々の
方法、例えばスーパーオキシドジスムターゼ(SOD)
を共存させ、反応後に液性を酸性とする方法(特公昭5
9−66899号公報)、或は反応液の液性を一旦酸性
とした後に発色試薬を加えて比色定量する方法(特公昭
59−2280号公報)等が報告されている。しかしな
がら、これらの方法は測定のステップ数が増加する為操
作が繁雑となるし、酵素活性を測定するための所謂レイ
ト法には適用てきないものであった。また、これら以外
にも微生物由来の特別なXODを使用することにより上
記問題点を回避している報告(特公昭55−10829
8号公報)もあるがこれに使用できる酵素(XOD)は
限定されており、更なる改良が望まれていた。Therefore, in order to solve these problems in the method of measuring hydrogen peroxide produced by the action of XOD, various methods are used, such as superoxide dismutase (SOD).
A method of making the liquid coexist and making the liquid acidic after the reaction (Tokuko Kokko 5th
9-66899 (Japanese Patent Publication No. 59-2280), or a method in which colorimetric determination is carried out by adding a coloring reagent after once making the reaction liquid acidic (Japanese Patent Publication No. 59-2280) has been reported. However, these methods require complicated operations due to the increased number of measurement steps, and have not been applicable to the so-called late method for measuring enzyme activity. In addition to these, there are also reports (Japanese Patent Publication No. 55-10829
8), but the enzymes (XOD) that can be used for this are limited, and further improvements have been desired.
また、簀機リンの測定方法としては、Fiske−5u
bbaRow法(J、Biol、Chem、、J6,3
75頁、1925)が一般に用いられているが、強酸を
使用している為に、自動分析装置の使用材料への影響が
懸念され、新規な自動分析!a置への応用が可能な測定
法の確立が望まれていた。In addition, as a method for measuring phosphorus on a screen, Fiske-5u
bbaRow method (J, Biol, Chem, J6,3
75, 1925) is commonly used, but since it uses a strong acid, there are concerns that it may affect the materials used in the automatic analyzer, so a new automatic analysis! It has been desired to establish a measurement method that can be applied to a position.
[発明の目的]
本発明は、上記した如き状況に鑑みなされたもので、X
ODの作用を介して生成する過酸化水素の定量方法に於
いて、従来より改善が求められていた種々の問題点をす
べて解決した、正確で簡便な定量方法を提供することを
目的とする。[Object of the invention] The present invention was made in view of the above-mentioned circumstances, and
The purpose of the present invention is to provide an accurate and simple method for quantifying hydrogen peroxide produced through the action of OD, which solves all the various problems that have conventionally been sought for improvement.
[発明の構成]
本発明の目的を達成する為に、本発明は次の構成よりな
る。[Configuration of the Invention] In order to achieve the object of the present invention, the present invention has the following configuration.
rXODの作用を介して生成する過酸化水素の測定方法
に於いて、過酸化水素生成系にマンガン及び/叉はコバ
ルトの水溶性化合物を加えて、これを行うことを特徴と
する過酸化水素の定量方法。」即ち、本発明者らは、例
えばヒボキサンチン、或はキサンチンにXODが作用し
て生ずる過酸化水素を測定夕るに当り、過酸化水素と同
時に生成するスーパーオキサイドアニオンに起因して生
ずる種々の問題点を解決すべく、スーパーオキサイドア
ニオンを過酸化水素に定量的に変化させる物質について
鋭意研究を行ったところ、マンガン及びコバルトの水溶
性化合物が、その目的を達成し得るものであることを見
い出し本発明を完成するに至った。A method for measuring hydrogen peroxide produced through the action of rXOD, which is characterized by adding a water-soluble compound of manganese and/or cobalt to the hydrogen peroxide production system. Quantification method. In other words, when the present inventors measure hydrogen peroxide produced by the action of XOD on hyboxanthin or xanthine, for example, various problems arise due to superoxide anions produced simultaneously with hydrogen peroxide. In order to solve this problem, we conducted intensive research on substances that quantitatively convert superoxide anions into hydrogen peroxide, and discovered that water-soluble compounds of manganese and cobalt could achieve this purpose. The invention was completed.
本発明に用いられるマンガン若しくはコバルトの水溶性
化合物としては、例えば酢酸マンガン。Examples of the water-soluble manganese or cobalt compound used in the present invention include manganese acetate.
アセチルアセトンマンガンJC#アンモニウムマンガン
、安息香酸マンガン、p−アミノ安息香酸マンガン、ホ
ウ酸マンガン、n−酪酸マンガン、炭酸マンガン、塩化
マンガン、4−シクロヘキシル酪酸マンガン、2−エチ
ルヘキサンマンガン、ギ酸マンガン、硝酸マンガン、リ
ン酸マンガン(塩基性)。Acetylacetone manganese JC #Ammonium manganese, manganese benzoate, manganese p-aminobenzoate, manganese borate, manganese n-butyrate, manganese carbonate, manganese chloride, manganese 4-cyclohexylbutyrate, 2-ethylhexane manganese, manganese formate, manganese nitrate , manganese phosphate (basic).
硫酸マンガン、 M rr E D T A 、ヘキサ
フルオロアセチルアセトンマンガン、トリフルオロアセ
チルアセトンマンガン、臭化マンガン、グルコン酸マン
ガン等や、例えば塩化コバルト、臭化コバルト。Manganese sulfate, MrrEDTA, manganese hexafluoroacetylacetone, manganese trifluoroacetylacetone, manganese bromide, manganese gluconate, and, for example, cobalt chloride, cobalt bromide.
硫酸コバルト、硝酸コバルト、酢酸コバル)、M酸アン
モニウムコバルト、ヘキサアンミンコバルト塩化物等の
、マンガン或はコバルトの、水溶性塩類(錯塩を含む)
や水溶性キレート化合物が挙げられるが、特に2価のマ
ンガンイオン(Mn2+)、2価のコバルトイオン(C
o2”)のそれがより好ましく用いられる。これらマン
ガン又はコバルトの水溶性化合物は夫々単独で用いても
よいし、適宜2種以上組み合わせて用いてもよく、その
使用量としては、系内に合計で少なくとも0.O1■門
以上存在させることが最低必要条件であるが、通常0.
1〜30m門の範囲が好ましく用いられる。Water-soluble salts (including complex salts) of manganese or cobalt, such as cobalt sulfate, cobalt nitrate, cobalt acetate), ammonium cobalt M acid, and hexaammine cobalt chloride.
and water-soluble chelate compounds, but especially divalent manganese ions (Mn2+) and divalent cobalt ions (C
o2") is more preferably used. These manganese or cobalt water-soluble compounds may be used alone or in combination of two or more, and the amount used is the total amount in the system. The minimum requirement is for the presence of at least 0.01 mm, but usually 0.
A range of 1 to 30 m is preferably used.
本発明の好ましい実施態様の1つは、マンガン又は/及
びコバルトの水溶性化合物と金属キレート剤とを併用す
る方法である。即ち、金属キレート剤をマンガン又は/
及びコバルトの水溶性化合物と併用させることにより、
XODの作用を受けて生成する過酸化水素をより高感度
に測定することができ、核酸代謝に関する物質のより高
感度な測定が可能となる。One of the preferred embodiments of the present invention is a method of using a water-soluble compound of manganese or/and cobalt in combination with a metal chelating agent. That is, the metal chelating agent is manganese or/
By using it together with a water-soluble compound of cobalt,
Hydrogen peroxide produced under the action of XOD can be measured with higher sensitivity, and substances related to nucleic acid metabolism can be measured with higher sensitivity.
このような目的で用いられる金属キレート剤としては、
例えばエチレンジアミン四酢酸(EDTA)、シクロヘ
キサンジアミン四酢酸(CyDTA)、ジエチレントリ
アミン五酢fi(DTPA)等が挙げられるが、特にこ
れらに限定されるものではなく、マンガン或はコバルト
とキレートを形成し得るものであればいずれにてもよい
。これら金属キレート剤は単独で用いても2種以上組み
合わせて用いてもよく、その使用濃度としては用いる水
溶性金属化合物のモル濃度と同等乃至それ以上の濃度で
あればよい。Metal chelating agents used for this purpose include:
Examples include, but are not limited to, ethylenediaminetetraacetic acid (EDTA), cyclohexanediaminetetraacetic acid (CyDTA), diethylenetriaminepentaacetic acid fi (DTPA), etc., and substances that can form chelates with manganese or cobalt. Either is fine. These metal chelating agents may be used alone or in combination of two or more, and their concentration may be equivalent to or higher than the molar concentration of the water-soluble metal compound used.
本発明の方法により測定可能な物質としては、例えばX
ODの基質となるキサンチン、ヒボキサンチン等、或は
適当な酵素反応によりこれらの物質に変換されるアデノ
シン、イノシン、グアニン等、又は上記した如き物質を
産生ずるアデノシンデアミナーゼ、プリンヌクレオシド
ホスホリラーゼ、グアナーゼ等の酵素、無機リン等が挙
げられるが、最終的にXODの作用により過酸化水素を
発生させる反応系に導けるものであれば特に限定されな
い。Examples of substances that can be measured by the method of the present invention include X
Xanthine, hyboxanthin, etc., which are substrates for OD, or adenosine, inosine, guanine, etc., which are converted into these substances by appropriate enzymatic reactions, or enzymes such as adenosine deaminase, purine nucleoside phosphorylase, guanase, etc., which produce the above-mentioned substances. , inorganic phosphorus, etc., but there is no particular limitation as long as it can lead to a reaction system that ultimately generates hydrogen peroxide by the action of XOD.
本発明に用いられるXODは牛乳由来及び微生物由来の
いずれのものでもよい。The XOD used in the present invention may be derived from milk or microorganisms.
本発明の定量方法は、過酸化水素生成系内にマンガン又
は/及びコバルトの水溶性化合物を加えるか、或はこれ
に更に金属キレート剤を加えること以外は、XODの作
用を介して生成する過酸化水素をPODと被酸化性呈色
試薬を用いて比色定置する自体公知の方法に従ってこれ
を行えばよく、用いられる測定試薬も、自体公知の測定
法に於いて用いられる試薬を用いることで足りる。即ち
、PODは植物由来、動物由来、微生物由来のいずれに
てもよいが、通常は西洋ワサビ由来のものが好ましく用
いられ、被酸化性呈色試薬としては通常過酸化水素−P
OD系で用いられている、例えば4−アミノアンチピリ
ンと、フェノール系化合物又はN、N−ジ置換アニリン
系化合物とを組み合わせた被酸化性呈色試薬、3−メチ
ルベンゾチアゾリノンヒドラゾン(MBTH)とアニリ
ン系化合物との組み合わせ試薬、トリフェニルメタン系
ロイコ色素、ベンジジン誘導体、0−トリジン誘導体、
ジフェニルアミン誘導体、トリアリルイミダゾール読導
体、ロイコメチレンブルー誘導体、0−フェニレンジア
ミン、2.2′−アミノビス(3−エチルヘンジチアゾ
リン−6−スルホン酸)又はその塩などが挙げられるが
、これらに限定されるものではない。The quantitative method of the present invention does not require the addition of a water-soluble manganese or/and cobalt compound to the hydrogen peroxide production system, or the addition of a metal chelating agent to the hydrogen peroxide production system. This can be carried out according to a method known per se in which hydrogen oxide is colorimetrically fixed using POD and an oxidizable coloring reagent, and the measuring reagent used can be a reagent used in a method known per se. Enough. That is, POD may be derived from plants, animals, or microorganisms, but it is usually preferably derived from horseradish, and the oxidizable coloring reagent is usually hydrogen peroxide-P.
3-Methylbenzothiazolinone hydrazone (MBTH) is an oxidizable coloring reagent used in OD systems, such as a combination of 4-aminoantipyrine and a phenol compound or an N,N-disubstituted aniline compound. and aniline compound, triphenylmethane leuco dye, benzidine derivative, 0-tolidine derivative,
Examples include, but are not limited to, diphenylamine derivatives, triallylimidazole readers, leucomethylene blue derivatives, 0-phenylenediamine, 2,2'-aminobis(3-ethylhendithiazoline-6-sulfonic acid) or salts thereof, etc. It's not a thing.
また、測定試薬の液性の調整に用いられる緩衝剤も通常
使用されるものであれば特に限定されないが、例えばリ
ン酸塩緩衝剤、トリス緩衝剤、グツド緩衝剤等が挙げら
れる。但し、無機リンの測定には、リン酸塩緩衝剤以外
の緩衝剤を使用しなくてはならないことは言うまでもな
い。測定試薬の液性(pH)は、測定対象物質、XOD
と共役して用いられる酵素等の至適1)H等の考慮が必
要であるが、通常はpH6〜10の範囲が好ましく用い
られる。測定時の温度としては、目的とする反応が進行
する温度であれば特に限定されないが、通常25〜40
℃の範囲が好ましく用いられる。尚、本発明に用いられ
る測定試薬中には、測定対象物質に応して必要な基質や
共役酵素が必要濃度添加されることは言うまでもない。Furthermore, the buffer used to adjust the liquid properties of the measurement reagent is not particularly limited as long as it is commonly used, and examples thereof include phosphate buffer, Tris buffer, Gud buffer, and the like. However, it goes without saying that for the measurement of inorganic phosphorus, a buffer other than the phosphate buffer must be used. The liquid property (pH) of the measurement reagent is determined by the substance to be measured, XOD
Although it is necessary to consider the optimum 1) H of the enzyme used in conjugation with the enzyme, a pH range of 6 to 10 is usually preferably used. The temperature at the time of measurement is not particularly limited as long as it is a temperature at which the desired reaction proceeds, but it is usually between 25 and 40°C.
A range of 0.degree. C. is preferably used. It goes without saying that the measurement reagent used in the present invention contains necessary substrates and conjugated enzymes at a required concentration depending on the substance to be measured.
本発明の方法に於いて、アスコルビン酸、ビリルビン等
の測定妨害物質を含むものを試料とする場合には、アス
コルビン酸オキシダーゼ、ビリルビンオキシダーゼ等の
酵素を用いる方法や、沃素酸塩、過沃素酸塩を用いる方
法など従来から良く知られた方法で処理してもよいし、
また、特開昭60−262599号公報に記載の方法、
即ち、銅イオン及びPODとアニリン系化合物、フェノ
ール系化合物、4−アミノアンチピリン等を併用するこ
とによって処理してもよく、これらのうちの適当な方法
に従って処理することによりこれらの影響を軽減するこ
とができる。In the method of the present invention, when the sample contains substances that interfere with measurement such as ascorbic acid and bilirubin, methods using enzymes such as ascorbic acid oxidase and bilirubin oxidase, or methods using iodate and periodate are used. It may be processed by a conventionally well-known method such as a method using
Also, the method described in JP-A No. 60-262599,
That is, the treatment may be performed by using copper ions and POD in combination with aniline compounds, phenol compounds, 4-aminoantipyrine, etc., and the effects of these can be reduced by treatment according to an appropriate method among these. Can be done.
本発明の方法は、通常lステップの操作で測定可能であ
るが、妨害物質の除去を行う前処理操作等を加えて2ス
テツプの操作としてもよいし、また、測定対象物質を酵
素とした場合には、反応停止液を用いた2ステツプの操
作、或は前述の如き前処理操作を加えて3ステツプの操
作として行ってもよい。The method of the present invention can normally be measured in one step, but it may also be a two-step operation by adding a pretreatment operation to remove interfering substances, or when the target substance to be measured is an enzyme. This may be carried out as a two-step operation using a reaction stop solution, or as a three-step operation by adding a pretreatment operation as described above.
以下に実施例により、本発明をさらに具体的に説明する
が、本発明はこれらにより何ら限定されるものではない
。EXAMPLES The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited to these in any way.
[実施例]
実施例1.ヒボキサンチンの定量
(測定試薬)
0.1M N−(2−アセタミド)−2−アミノエタン
スルホン酸(ACES)・NaOH緩衝液に下記物質を
下記濃度となるように溶解して測定試薬とした。[Example] Example 1. Quantification of Hyboxanthin (Measurement Reagent) A measurement reagent was prepared by dissolving the following substance in a 0.1M N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)/NaOH buffer to the following concentration.
X OD
0.04U/s+IP OD
4U/m1N−エチル−N−(2
−ヒドロキシ−3−スルホプロピル)−s−トルイジン
(TOO5) 260曙g/14−アミノアン
チピリン 90■g/IMnC12114H
201mM
(試料)
ヒボキサンチンを夫々3.2.6.4.9.6.12.
8■−含む水溶液を調製し試料とした。XOD
0.04U/s+IP OD
4U/m1N-ethyl-N-(2
-Hydroxy-3-sulfopropyl)-s-toluidine (TOO5) 260g/14-aminoantipyrine 90g/IMnC12114H
201mM (sample) Hyboxanthin 3.2.6.4.9.6.12.
An aqueous solution containing 8■- was prepared and used as a sample.
(操作法)
試料を10μmとり、測定試薬2.51を加えてよく混
合し、37℃で5公園反応させた後、555n−に於け
る吸光度Eqを測定した。(Procedure) A 10 μm sample was taken, a measuring reagent 2.51 was added thereto, mixed well, and subjected to a five-park reaction at 37° C., and then the absorbance Eq at 555 n− was measured.
試料の代りに精製水を用いて同様の操作を行い試薬ブラ
ンクFBIを測定した。A similar operation was performed using purified water instead of the sample to measure the reagent blank FBI.
(結果)
横軸のヒボキサンチン濃度に対して得られた吸光度(E
s Eel)を縦軸に沿ってプロットした点を結んで
得られる検量線を第1図に示す(−Δ−)。(Results) The absorbance (E
A calibration curve obtained by connecting the points plotted along the vertical axis is shown in FIG. 1 (-Δ-).
実施例2゜
実施例Iの測定試薬のMnC12・4H20の代りにC
oCl2・6H20を1mM溶解したものを測定試薬と
した以外は実施例1と同様の測定試薬を用い、実施例1
と同様の操作により実施例1と同し試料について測定を
行った。Example 2 C instead of MnC12.4H20 in the measurement reagent of Example I
Example 1 was carried out using the same measurement reagent as in Example 1, except that the measurement reagent was a 1mM solution of oCl2.6H20.
Measurement was performed on the same sample as in Example 1 using the same procedure as in Example 1.
(結果)
横軸のヒボキサンチン濃度にたいして得られた吸光度(
Es−Eel)を縦軸に沿ってプロットした点を結んで
得られる検量線を第1図に併せて示す(−0−)。(Results) The absorbance obtained for the hypoxanthin concentration on the horizontal axis (
A calibration curve obtained by connecting the points plotted along the vertical axis (-0-) is also shown in FIG.
第1図から明らかな如く、実施例1及び2により得られ
た本発明に係わる検量線は、何れも原点を通る直線とな
り、良好な定量性を示した。As is clear from FIG. 1, the calibration curves according to the present invention obtained in Examples 1 and 2 were both straight lines passing through the origin, indicating good quantitative properties.
実施例3.′
(測定試薬)
実施例1の測定試薬にE D T A−2Na 1mM
を加えたものを測定試薬とした。Example 3. ' (Measurement reagent) EDTA-2Na 1mM was added to the measurement reagent of Example 1.
The mixture to which was added was used as the measurement reagent.
(試料) 実施例1と同じ。(sample) Same as Example 1.
(操作法) 実施例Iと同し。(Operation method) Same as Example I.
(結果)
横軸の一ヒボキサンチン濃度に対して得られた喚光度(
Es−EBt)を縦軸に沿ってプロットした点を結んで
得られる検量線を第2図に示す(−〇−)。(Results) The luminous intensity obtained for each hypoxanthin concentration on the horizontal axis (
A calibration curve obtained by connecting the points plotted along the vertical axis of Es-EBt) is shown in FIG. 2 (-〇-).
比較例1゜
実施例3の測定試薬からMnCl2・4H20及びED
TA−2Naを除いたものを測定試薬とした以外は実施
例3と同様の測定試薬を用い、実施例3と同様の操作に
より実施例3と同じ試料について測定を行った。Comparative Example 1゜MnCl2・4H20 and ED from the measurement reagent of Example 3
The measurement was performed on the same sample as in Example 3 using the same measurement reagent as in Example 3, except that TA-2Na was omitted, and in the same manner as in Example 3.
結果を第2図に併せて示す(−へ一)。The results are also shown in Figure 2 (-).
比較例2゜
比較例1の測定試薬にスーパーオキシドジスムターゼ(
SOD)を50Ul園1となるように添加したものを測
定試薬とした以外は実施例3と同様の測定試薬を用い、
実施例3と同様の操作により実施例3と同じ試料につい
て測定を行った。Comparative Example 2゜ Superoxide dismutase (
The same measurement reagent as in Example 3 was used, except that 50Ul of SOD) was added to the measurement reagent.
The same sample as in Example 3 was measured by the same operation as in Example 3.
結果を第2図に併せて示す<−X−> 。The results are also shown in FIG. 2 <-X->.
第2図から明らかな如く、本発明の方法による実施例3
に於いて得られた検量線は、比較例1又は2に於いて得
られたそれと比べ、測定感度及び直線性において優れて
おり、また、マンガンの水溶性化合物と金属キレート剤
(E D T A−2Na)を併用したことにより金属
キレート剤を併用しない実施例1及び2て得られた検量
線よりも測定感度が一段と高いことがわかる。As is clear from FIG. 2, Example 3 according to the method of the present invention
The calibration curve obtained in Comparative Example 1 or 2 was superior in measurement sensitivity and linearity. It can be seen that the combined use of -2Na) resulted in a much higher measurement sensitivity than the calibration curves obtained in Examples 1 and 2 in which no metal chelating agent was used.
参考例1゜ (測定試薬) 実施例3と同じ。Reference example 1゜ (Measurement reagent) Same as Example 3.
(試料)
過酸化水素を夫々6.4.I2.8.+9.2,25.
6mM含むI8液を調製し、試料とした。(Sample) Add hydrogen peroxide to 6.4. I2.8. +9.2,25.
I8 solution containing 6mM was prepared and used as a sample.
<Pk作法) 実施例3と同じ。<Pk etiquette) Same as Example 3.
(結果)
得られた吸光度(Es−Eat)を実施例3て得られた
結果と併せて表−1に示す。(Results) The obtained absorbance (Es-Eat) is shown in Table 1 together with the results obtained in Example 3.
以下余白
表−1
ヒボキサンチンl当量はXODとの反応により理論上は
2当量の過酸化水素を生成する。即ち、表−1から明ら
かな如く、本発明の方法によればヒボキサンチンから理
論遣の過酸化水素が生成していることが判る。Margin Table-1 Theoretically, 1 equivalent of hypoxanthin produces 2 equivalents of hydrogen peroxide by reaction with XOD. That is, as is clear from Table 1, it can be seen that according to the method of the present invention, the theoretical amount of hydrogen peroxide is produced from hyboxanthin.
実Ai!fIJ4a、j!!機’)ンノ定m(測定試薬
)
0.1M N−(2−7セタミド)−2−アミノエタン
スルホン酸(ACES)・Na0ll緩衝液に下記物質
を下記濃度となるように溶解して測定試薬とした。Real Ai! fIJ4a,j! ! (Measurement reagent) Dissolve the following substances in 0.1M N-(2-7cetamido)-2-aminoethanesulfonic acid (ACES) Na0ll buffer solution to the following concentration to prepare the measurement reagent. And so.
X OD O,04U/a+
1POD 4υ1IN−
エチル−N−(2−ヒドロキシ−3−スルホプロピル)
1−トルイジン(TOOS ) 260mg/
lドアミノアンチピリン 9抛g/IMn
C12・4H201mM
EDTA−2Na Im門プリン
ヌクレオシドホスホリラーゼ0.4U/mlイノシン
2sM(試料)
無機リンを夫々10.20.30.40園gl旧含む水
溶液を:AS1し試料とした。X OD O,04U/a+
1POD 4υ1IN-
Ethyl-N-(2-hydroxy-3-sulfopropyl)
1-Toluidine (TOOS) 260mg/
l-doaminoantipyrine 9g/IMn
C12・4H201mM EDTA-2Na Im purine nucleoside phosphorylase 0.4U/ml inosine
2sM (sample) An aqueous solution containing 10, 20, 30, and 40 grams of inorganic phosphorus, respectively, was prepared as an AS1 sample.
(操作法)
試料を10μmとり、測定試薬2.51を加えてよく混
合し、37℃で5分m反応させた後、555nmに於け
る吸光度Esを測定した。(Procedure) A 10 μm sample was taken, a measurement reagent 2.51 was added thereto, mixed well, reacted at 37° C. for 5 minutes, and then the absorbance Es at 555 nm was measured.
試料の代りに精製水を用いて同様の操作を行い試薬ブラ
ンクE81を測定した。A similar operation was performed using purified water instead of the sample to measure reagent blank E81.
(結果)
横軸の無機リン濃度(l1g/旧)に対して得られた吸
光度(Es EBI)を縦軸に沿ってプロットした点
を結んで得られる検量線を第3図に示す。(Results) FIG. 3 shows a calibration curve obtained by connecting the points obtained by plotting the obtained absorbance (Es EBI) along the vertical axis against the inorganic phosphorus concentration (l1g/old) on the horizontal axis.
第3図から明らかな如く、得られた検量線は、原点を通
る直線となり良好な定量性を示した。As is clear from FIG. 3, the obtained calibration curve was a straight line passing through the origin, indicating good quantitative properties.
実施例5.血清中の無機リンの定量 (測定試薬) 実施例4と同じ。Example 5. Determination of inorganic phosphorus in serum (Measurement reagent) Same as Example 4.
(試I′4) 人血清10検体を試料とした。(Trial I'4) Ten human serum samples were used as samples.
(操作法〉
試料を108mとり、測定試薬2.5mlを加えてよく
混合し、37℃で5公園反応させた後、555n■に於
ける吸光度ESを測定した。(Procedure) A 108 m sample was taken, 2.5 ml of the measurement reagent was added thereto, mixed well, and reacted at 37° C., after which the absorbance ES at 555 nm was measured.
試料の代りに精製水及び農機リン標準液(電機リンIO
++8/旧含有)を用いて同様の操作を行い試薬ブラン
クEa+及び標準液吸光度E s+、lを測定した。Purified water and agricultural machinery phosphorus standard solution (denki phosphorus IO) can be used instead of the sample.
++8/old content), the reagent blank Ea+ and the standard solution absorbance E s+,l were measured.
得られた吸光度を用いて次式により試料中の農機リン濃
度P(+s3/dl)を算出した。Using the obtained absorbance, the agricultural machinery phosphorus concentration P (+s3/dl) in the sample was calculated using the following formula.
P (mg/dl)”((Es−Es+)÷(Es+d
−EBI))XIO(結果)
測定結果を表−2に示す。P (mg/dl)”((Es-Es+)÷(Es+d
-EBI))XIO (Results) The measurement results are shown in Table-2.
比較例3.従来法による血清中のWt機リンの定量市販
の無機リン測定試薬[無機リンC−テストフコ−(和光
純薬工業(株)製)]を用い、実施例5と同じ試料につ
いて無機リンの定量を行った。Comparative example 3. Quantification of Wt organophosphorus in serum by conventional method Quantification of inorganic phosphorus was carried out for the same sample as in Example 5 using a commercially available inorganic phosphorus measuring reagent [Inorganic phosphorus C-Test Fuco (manufactured by Wako Pure Chemical Industries, Ltd.)]. went.
尚、操作法は、同瀾定試薬の現品説明書に従って行った
。The procedure was carried out according to the instruction manual for the detection reagent.
(結果) 測定結果を表−2に併せて示す。(result) The measurement results are also shown in Table-2.
表−2
相関係数:γ:0.999
回帰直線式: Y = 1.003 X −0,03表
−2から明らかな如〈実施例5で得られた値と比較例3
で得られた値とは良く一致しておりその間に有意差は認
められなかった。Table 2 Correlation coefficient: γ: 0.999 Regression linear equation: Y = 1.003
There was good agreement with the values obtained in , and no significant difference was observed between them.
[発明の効果]
以上述べた如く、本発明はXODを介して生成する過酸
化水素の、正確、且つ簡便で、しかも自動分析機に応用
可能な測定方法を提供するものであり、これにより例え
ば核酸代謝に関与する物質等を容易に且つより正確に測
定することが可能となった点に顕著な効果を奏する。[Effects of the Invention] As described above, the present invention provides a method for measuring hydrogen peroxide produced via XOD that is accurate and simple and can be applied to an automatic analyzer. This method has a remarkable effect in that it has become possible to easily and more accurately measure substances involved in nucleic acid metabolism.
第1図は、実施例1及び実施例2により得られた検量線
を示し、横軸のヒボキサンチン濃度(mM)に対して得
られた吸光度を縦軸に沿ってプロットした点を結んだも
のである。ここで、−へ一は実施例1で得られた結果を
、−〇−は実施例2て得られた結果を各々示す。
第2図は、実施例3、比較例1及び比較例2により得ら
れた検量線を示し、横軸のヒボキサンチン濃度(mM)
に対して得られた吸光度を縦軸に沿ってプロットした点
を結んだものである。ここて、−0−は実施例3て得ら
れた結果を、−Δ−は比較例1て得られた結果を、−×
−は比較例2で得られた結果を各々示す。
第3図は、実施例4により得られた検量線を示し、横軸
の麺機リン濃度(sg/dl)に対して得られた吸光度
を縦軸に沿ってプロットした点を結んだものである。
特許出願人 相光純薬工業株式会社
第1図
ヒポ°キブンナシ濃度(rr、M)
第2図
ヒポキサ〉チシ壇度(rnM)
M3図
無機り/1度(rngん1)Figure 1 shows the calibration curve obtained in Examples 1 and 2, connecting the points obtained by plotting the absorbance obtained against the hypoxanthin concentration (mM) on the horizontal axis and along the vertical axis. be. Here, -1 indicates the results obtained in Example 1, and -0- indicates the results obtained in Example 2. Figure 2 shows the calibration curves obtained in Example 3, Comparative Example 1, and Comparative Example 2, with the horizontal axis representing the hyboxanthin concentration (mM).
It connects the points obtained by plotting the absorbance obtained for the vertical axis along the vertical axis. Here, -0- is the result obtained in Example 3, -Δ- is the result obtained in Comparative Example 1, -×
- indicates the results obtained in Comparative Example 2. Figure 3 shows the calibration curve obtained in Example 4, which connects the points obtained by plotting the absorbance obtained against the noodle machine phosphorus concentration (sg/dl) on the horizontal axis and along the vertical axis. be. Patent Applicant: Aiko Pure Chemical Industries, Ltd. Figure 1 Hypoxa〉Kibunashi concentration (rr, M) Figure 2 Hypoxa〉 Tishidan degree (rnM) M3 diagram Inorganic/1 degree (rngn1)
Claims (2)
過酸化水素の定量方法に於いて、過酸化水素生成系にマ
ンガン又は/及びコバルトの水溶性化合物を加えて、こ
れを行うことを特徴とする過酸化水素の定量方法。(1) A method for quantifying hydrogen peroxide produced through the action of xanthine oxidase, which is characterized by adding a water-soluble compound of manganese or/and cobalt to the hydrogen peroxide production system. Method for quantifying hydrogen oxide.
属キレート剤とを併用する特許請求の範囲第1項に記載
の定量方法。(2) The quantitative method according to claim 1, in which a water-soluble compound of manganese or/and cobalt and a metal chelating agent are used in combination.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12786087A JPS63291594A (en) | 1987-05-25 | 1987-05-25 | Determination of hydrogen peroxide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12786087A JPS63291594A (en) | 1987-05-25 | 1987-05-25 | Determination of hydrogen peroxide |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63291594A true JPS63291594A (en) | 1988-11-29 |
Family
ID=14970448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12786087A Pending JPS63291594A (en) | 1987-05-25 | 1987-05-25 | Determination of hydrogen peroxide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63291594A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002063285A2 (en) * | 2001-02-07 | 2002-08-15 | Basf Aktiengesellschaft | Method for the online determination of hydrogen peroxide |
-
1987
- 1987-05-25 JP JP12786087A patent/JPS63291594A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002063285A2 (en) * | 2001-02-07 | 2002-08-15 | Basf Aktiengesellschaft | Method for the online determination of hydrogen peroxide |
WO2002063285A3 (en) * | 2001-02-07 | 2003-11-20 | Basf Ag | Method for the online determination of hydrogen peroxide |
US7351587B2 (en) | 2001-02-07 | 2008-04-01 | Basf Aktiengesellschaft | Method for the online determination of hydrogen peroxide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0577399B2 (en) | ||
JPH0470000B2 (en) | ||
Ishihara et al. | Enzymatic determination of ammonia in blood plasma | |
JPH04287695A (en) | Composition for analyzing ethanol | |
EP0193204B1 (en) | Process for determining superoxide dismutase activity | |
JP4639287B2 (en) | Stabilization method for enzymatic measurement reagents | |
JPH0571239B2 (en) | ||
JPS63291594A (en) | Determination of hydrogen peroxide | |
JP2000316600A (en) | Method for determining free fatty acid and reagent for determining free fatty acid | |
US5266472A (en) | Stabilization of the enzyme urate oxidase in liquid form | |
JP2515551B2 (en) | Novel method for quantifying hydrogen peroxide | |
JPH0635966B2 (en) | Analytical reagent useful for detecting thiol compound and detection method using the same | |
JPS61247963A (en) | Quantitatively determining method for vital material with ammonia as resulted product of reaction | |
JPH0313880B2 (en) | ||
US5108733A (en) | Stabilized trinder reagent | |
JPH05176797A (en) | Method for determining cholesterol and reagent for determination | |
JP3070726B2 (en) | Method for stabilizing sarcosine oxidase in solution | |
JP2775847B2 (en) | Fructosamine measurement reagent | |
JP3470099B2 (en) | Stabilized coenzyme solution for measuring dehydrogenase or its substrate and use thereof | |
US5206006A (en) | Stabilized trinder reagent | |
JPS5966899A (en) | Determination of hydrogen peroxide | |
JPS6342470A (en) | Method for measuring peroxidase or h2o2 | |
JPH06148168A (en) | Composite for peroxide active material detection | |
JPS61173799A (en) | Method of determining activity of substrate or enzyme | |
US5792619A (en) | Assay using oxidative chromogenic reagent |